

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 6.33079215 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 6.33079215 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.33227267 |
| 4 | positive regulation of keratinocyte differentiation (GO:0045618) | 4.89795841 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.69963335 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.69963335 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.44577614 |
| 8 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.39785718 |
| 9 | negative T cell selection (GO:0043383) | 4.34243044 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.29702462 |
| 11 | negative thymic T cell selection (GO:0045060) | 4.28561153 |
| 12 | leukocyte aggregation (GO:0070486) | 4.27230012 |
| 13 | desmosome organization (GO:0002934) | 4.26907822 |
| 14 | mast cell activation (GO:0045576) | 4.14646437 |
| 15 | regulation of water loss via skin (GO:0033561) | 4.11019327 |
| 16 | diol metabolic process (GO:0034311) | 4.10251694 |
| 17 | regulation of gamma-delta T cell activation (GO:0046643) | 4.06533107 |
| 18 | COPI coating of Golgi vesicle (GO:0048205) | 4.06052297 |
| 19 | Golgi transport vesicle coating (GO:0048200) | 4.06052297 |
| 20 | iron ion import (GO:0097286) | 4.01973375 |
| 21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.93160810 |
| 22 | hepatocyte apoptotic process (GO:0097284) | 3.85392228 |
| 23 | ensheathment of neurons (GO:0007272) | 3.82320939 |
| 24 | axon ensheathment (GO:0008366) | 3.82320939 |
| 25 | skin morphogenesis (GO:0043589) | 3.80403195 |
| 26 | hemidesmosome assembly (GO:0031581) | 3.78693267 |
| 27 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.77493453 |
| 28 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.76459431 |
| 29 | intestinal epithelial cell development (GO:0060576) | 3.71043248 |
| 30 | myelination (GO:0042552) | 3.69838792 |
| 31 | sphingosine metabolic process (GO:0006670) | 3.69650574 |
| 32 | T cell migration (GO:0072678) | 3.68263956 |
| 33 | positive thymic T cell selection (GO:0045059) | 3.61314871 |
| 34 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.59627590 |
| 35 | creatine metabolic process (GO:0006600) | 3.57647782 |
| 36 | interferon-gamma production (GO:0032609) | 3.57317026 |
| 37 | sphingoid metabolic process (GO:0046519) | 3.55455869 |
| 38 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.54942221 |
| 39 | negative regulation of cell killing (GO:0031342) | 3.54942221 |
| 40 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.53297370 |
| 41 | thymic T cell selection (GO:0045061) | 3.46816808 |
| 42 | tolerance induction (GO:0002507) | 3.46597485 |
| 43 | glycosphingolipid catabolic process (GO:0046479) | 3.45066542 |
| 44 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.44141491 |
| 45 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.42754729 |
| 46 | neutrophil activation involved in immune response (GO:0002283) | 3.42351097 |
| 47 | positive regulation of interleukin-2 production (GO:0032743) | 3.42335931 |
| 48 | myelin maintenance (GO:0043217) | 3.42124271 |
| 49 | amyloid precursor protein metabolic process (GO:0042982) | 3.39755487 |
| 50 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.39039521 |
| 51 | mast cell degranulation (GO:0043303) | 3.38810238 |
| 52 | mast cell activation involved in immune response (GO:0002279) | 3.38810238 |
| 53 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.38744963 |
| 54 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.38128035 |
| 55 | fatty acid elongation (GO:0030497) | 3.35815468 |
| 56 | GDP-mannose metabolic process (GO:0019673) | 3.32868197 |
| 57 | establishment of skin barrier (GO:0061436) | 3.26603877 |
| 58 | T cell receptor signaling pathway (GO:0050852) | 3.24175083 |
| 59 | T cell selection (GO:0045058) | 3.23877647 |
| 60 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.21844009 |
| 61 | regulation of keratinocyte differentiation (GO:0045616) | 3.21806207 |
| 62 | activated T cell proliferation (GO:0050798) | 3.19713174 |
| 63 | virion attachment to host cell (GO:0019062) | 3.19379761 |
| 64 | adhesion of symbiont to host cell (GO:0044650) | 3.19379761 |
| 65 | cellular copper ion homeostasis (GO:0006878) | 3.18948123 |
| 66 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.18202660 |
| 67 | positive regulation of epidermis development (GO:0045684) | 3.17200171 |
| 68 | amyloid precursor protein catabolic process (GO:0042987) | 3.16732868 |
| 69 | decidualization (GO:0046697) | 3.16390685 |
| 70 | response to interleukin-15 (GO:0070672) | 3.15889473 |
| 71 | oligosaccharide catabolic process (GO:0009313) | 3.13303299 |
| 72 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.12624988 |
| 73 | sphingomyelin metabolic process (GO:0006684) | 3.10128103 |
| 74 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.07463080 |
| 75 | T cell costimulation (GO:0031295) | 3.07133111 |
| 76 | glycolipid catabolic process (GO:0019377) | 3.07013667 |
| 77 | proline biosynthetic process (GO:0006561) | 3.06349572 |
| 78 | multicellular organismal water homeostasis (GO:0050891) | 3.06345824 |
| 79 | protein retention in ER lumen (GO:0006621) | 3.04217480 |
| 80 | positive T cell selection (GO:0043368) | 3.04056334 |
| 81 | lymphocyte costimulation (GO:0031294) | 3.03027521 |
| 82 | positive regulation of B cell differentiation (GO:0045579) | 3.00592594 |
| 83 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.99623020 |
| 84 | regulation of T cell tolerance induction (GO:0002664) | 2.99031891 |
| 85 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.96704669 |
| 86 | leukocyte cell-cell adhesion (GO:0007159) | 2.95209181 |
| 87 | positive regulation of interleukin-4 production (GO:0032753) | 2.93510174 |
| 88 | response to lipoprotein particle (GO:0055094) | 2.93205873 |
| 89 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.93084148 |
| 90 | ceramide catabolic process (GO:0046514) | 2.92781426 |
| 91 | interferon-gamma secretion (GO:0072643) | 2.92245169 |
| 92 | leukocyte degranulation (GO:0043299) | 2.91006614 |
| 93 | membrane raft organization (GO:0031579) | 2.90883693 |
| 94 | sphingolipid catabolic process (GO:0030149) | 2.90089689 |
| 95 | B cell receptor signaling pathway (GO:0050853) | 2.89265637 |
| 96 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.88998821 |
| 97 | membrane lipid catabolic process (GO:0046466) | 2.87438497 |
| 98 | positive regulation of tolerance induction (GO:0002645) | 2.86896490 |
| 99 | ear development (GO:0043583) | 2.86548071 |
| 100 | NIK/NF-kappaB signaling (GO:0038061) | 2.86525410 |
| 101 | cellular response to interleukin-15 (GO:0071350) | 2.84198126 |
| 102 | myeloid cell activation involved in immune response (GO:0002275) | 2.82992826 |
| 103 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.82833681 |
| 104 | respiratory burst (GO:0045730) | 2.81384704 |
| 105 | axonemal dynein complex assembly (GO:0070286) | 2.79319869 |
| 106 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.78147540 |
| 107 | positive regulation of interleukin-17 production (GO:0032740) | 2.76933094 |
| 108 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.76701010 |
| 109 | glycosylceramide metabolic process (GO:0006677) | 2.76374698 |
| 110 | regulation of regulatory T cell differentiation (GO:0045589) | 2.75926893 |
| 111 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.74275825 |
| 112 | protein localization to endosome (GO:0036010) | 2.73190780 |
| 113 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.72985678 |
| 114 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.72977846 |
| 115 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.70452522 |
| 116 | apoptotic cell clearance (GO:0043277) | 2.70317398 |
| 117 | positive regulation of T cell cytokine production (GO:0002726) | 2.70177042 |
| 118 | cell adhesion mediated by integrin (GO:0033627) | 2.69969940 |
| 119 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.68831622 |
| 120 | amino sugar catabolic process (GO:0046348) | 2.68619834 |
| 121 | regulation of B cell differentiation (GO:0045577) | 2.68351951 |
| 122 | T cell homeostasis (GO:0043029) | 2.67995708 |
| 123 | mannose metabolic process (GO:0006013) | 2.67622407 |
| 124 | positive regulation of tissue remodeling (GO:0034105) | 2.67527345 |
| 125 | motile cilium assembly (GO:0044458) | 2.65835430 |
| 126 | positive regulation of antigen processing and presentation (GO:0002579) | 2.64118296 |
| 127 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.62829662 |
| 128 | heterotypic cell-cell adhesion (GO:0034113) | 2.62434483 |
| 129 | positive regulation by symbiont of host defense response (GO:0052509) | 2.62175239 |
| 130 | modulation by symbiont of host defense response (GO:0052031) | 2.62175239 |
| 131 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.62175239 |
| 132 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.62175239 |
| 133 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.62175239 |
| 134 | modulation by symbiont of host immune response (GO:0052553) | 2.62175239 |
| 135 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.61757988 |
| 136 | keratinocyte development (GO:0003334) | 2.61098847 |
| 137 | regulation of interleukin-2 production (GO:0032663) | 2.60664807 |
| 138 | immunoglobulin mediated immune response (GO:0016064) | 2.60149510 |
| 139 | positive regulation of isotype switching (GO:0045830) | 2.56556637 |
| 140 | mammary gland epithelial cell proliferation (GO:0033598) | 2.55823980 |
| 141 | angiogenesis involved in wound healing (GO:0060055) | 2.55815869 |
| 142 | pinocytosis (GO:0006907) | 2.55679320 |
| 143 | primary alcohol catabolic process (GO:0034310) | 2.54939411 |
| 144 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.54719607 |
| 145 | endothelial cell chemotaxis (GO:0035767) | 2.54377685 |
| 146 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.54040686 |
| 147 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.53267827 |
| 148 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.53024607 |
| 149 | vagina development (GO:0060068) | 2.51990302 |
| 150 | response to peptidoglycan (GO:0032494) | 2.51519991 |
| 151 | regulation of tolerance induction (GO:0002643) | 2.51250892 |
| 152 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.51172397 |
| 153 | membrane protein ectodomain proteolysis (GO:0006509) | 2.51133739 |
| 154 | water homeostasis (GO:0030104) | 2.51017391 |
| 155 | ER overload response (GO:0006983) | 2.48455691 |
| 156 | neutrophil activation (GO:0042119) | 2.48186256 |
| 157 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.47181769 |
| 158 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.47007233 |
| 159 | vitamin transmembrane transport (GO:0035461) | 2.46463637 |
| 160 | * O-glycan processing (GO:0016266) | 2.46092899 |
| 161 | response to protozoan (GO:0001562) | 2.45925120 |
| 162 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.45063536 |
| 163 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.44486262 |
| 164 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.43501075 |
| 165 | myeloid dendritic cell activation (GO:0001773) | 2.42756516 |
| 166 | copper ion homeostasis (GO:0055070) | 2.42653934 |
| 167 | norepinephrine metabolic process (GO:0042415) | 2.42353532 |
| 168 | semaphorin-plexin signaling pathway (GO:0071526) | 2.42345672 |
| 169 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.42070063 |
| 170 | glutathione biosynthetic process (GO:0006750) | 2.42012588 |
| 171 | cytokine biosynthetic process (GO:0042089) | 2.41242806 |
| 172 | regulation of vitamin metabolic process (GO:0030656) | 2.40180690 |
| 173 | defense response to protozoan (GO:0042832) | 2.40062848 |
| 174 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.39140869 |
| 175 | epithelial cell-cell adhesion (GO:0090136) | 2.38952843 |
| 176 | tRNA methylation (GO:0030488) | 2.37905532 |
| 177 | tight junction assembly (GO:0070830) | 2.36462743 |
| 178 | cell differentiation involved in embryonic placenta development (GO:0060706) | 2.28379375 |
| 179 | barbed-end actin filament capping (GO:0051016) | 2.27883242 |
| 180 | cellular response to exogenous dsRNA (GO:0071360) | 2.27644288 |
| 181 | muscle cell migration (GO:0014812) | 2.25408739 |
| 182 | response to vitamin D (GO:0033280) | 2.24947664 |
| 183 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.24869899 |
| 184 | response to water (GO:0009415) | 2.24436310 |
| 185 | glucose catabolic process (GO:0006007) | 2.21996417 |
| 186 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.21623477 |
| 187 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.20107348 |
| 188 | positive regulation of bone resorption (GO:0045780) | 2.19880195 |
| 189 | positive regulation of bone remodeling (GO:0046852) | 2.19880195 |
| 190 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.19718801 |
| 191 | autophagic vacuole fusion (GO:0000046) | 2.19660023 |
| 192 | N-acetylneuraminate metabolic process (GO:0006054) | 2.19211086 |
| 193 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.16797064 |
| 194 | regulation of viral release from host cell (GO:1902186) | 2.16411189 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.19167670 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.66880733 |
| 3 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.78559359 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.71114110 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.57122428 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.56727136 |
| 7 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.52915032 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.45230047 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.43535643 |
| 10 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.37061128 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.97331285 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.96649276 |
| 13 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.83655795 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.80924408 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.80364568 |
| 16 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.73583960 |
| 17 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.73167764 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.71434234 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.63748994 |
| 20 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.61890284 |
| 21 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.61286734 |
| 22 | * MYB_26560356_Chip-Seq_TH2_Human | 2.60796931 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.60523840 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.55340761 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.54380660 |
| 26 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 2.39661088 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.35615720 |
| 28 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.34049750 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 2.30730599 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.30648193 |
| 31 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.30063878 |
| 32 | MYC_22102868_ChIP-Seq_BL_Human | 2.28736736 |
| 33 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.22387334 |
| 34 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.21060552 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.18741962 |
| 36 | UTX_26944678_Chip-Seq_JUKART_Human | 2.16773119 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.15292697 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 2.15178415 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.10905450 |
| 40 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.07014613 |
| 41 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 2.00085426 |
| 42 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.97472274 |
| 43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.94656746 |
| 44 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.94240690 |
| 45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.88476357 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.88389473 |
| 47 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.79029574 |
| 48 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.78175231 |
| 49 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.75583586 |
| 50 | * MAF_26560356_Chip-Seq_TH2_Human | 1.75262644 |
| 51 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.74878742 |
| 52 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.74689449 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72226680 |
| 54 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.71428171 |
| 55 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.65377168 |
| 56 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.64999883 |
| 57 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.62056549 |
| 58 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.62056549 |
| 59 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.61892846 |
| 60 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.61346046 |
| 61 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.61185712 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.60573817 |
| 63 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.57840914 |
| 64 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.57229511 |
| 65 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.56894046 |
| 66 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.55555774 |
| 67 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.53687645 |
| 68 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.51096293 |
| 69 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.50985148 |
| 70 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50199588 |
| 71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.49043493 |
| 72 | ATF3_27146783_Chip-Seq_COLON_Human | 1.47066951 |
| 73 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.46477249 |
| 74 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.45819181 |
| 75 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45715637 |
| 76 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43541011 |
| 77 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43284631 |
| 78 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.39289036 |
| 79 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38011139 |
| 80 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.36817538 |
| 81 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34519104 |
| 82 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34390269 |
| 83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.33860051 |
| 84 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33099445 |
| 85 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.32881247 |
| 86 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.31455685 |
| 87 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.30835472 |
| 88 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28693262 |
| 89 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28471939 |
| 90 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.27868843 |
| 91 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24807490 |
| 92 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.23821123 |
| 93 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.22667943 |
| 94 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.22610366 |
| 95 | GATA3_26560356_Chip-Seq_TH2_Human | 1.22454820 |
| 96 | GATA1_19941826_ChIP-Seq_K562_Human | 1.21801875 |
| 97 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.20469522 |
| 98 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19501104 |
| 99 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18982369 |
| 100 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18698006 |
| 101 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.18530893 |
| 102 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.17366281 |
| 103 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16523304 |
| 104 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15590931 |
| 105 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15203509 |
| 106 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.14818395 |
| 107 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13906653 |
| 108 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.11590509 |
| 109 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.11108590 |
| 110 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09918331 |
| 111 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09410032 |
| 112 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06744583 |
| 113 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.06071488 |
| 114 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.05780799 |
| 115 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.05161922 |
| 116 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04957648 |
| 117 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.04153074 |
| 118 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.03892233 |
| 119 | * P68_20966046_ChIP-Seq_HELA_Human | 1.03559985 |
| 120 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.02476843 |
| 121 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.02102311 |
| 122 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.01811176 |
| 123 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.01206531 |
| 124 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00526973 |
| 125 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99583469 |
| 126 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.98846111 |
| 127 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.98695318 |
| 128 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98570836 |
| 129 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98293342 |
| 130 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.98195261 |
| 131 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.97562231 |
| 132 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.97515472 |
| 133 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97256465 |
| 134 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.95884962 |
| 135 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95645133 |
| 136 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95008063 |
| 137 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.93692336 |
| 138 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92764834 |
| 139 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.92696261 |
| 140 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.91798411 |
| 141 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.91365077 |
| 142 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90962794 |
| 143 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90925589 |
| 144 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88588969 |
| 145 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.87922919 |
| 146 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.85922946 |
| 147 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81048604 |
| 148 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.80786567 |
| 149 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.78603706 |
| 150 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.78586463 |
| 151 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.74818670 |
| 152 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.74335662 |
| 153 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73862470 |
| 154 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.73511538 |
| 155 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.73422398 |
| 156 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72507297 |
| 157 | GATA1_22025678_ChIP-Seq_K562_Human | 0.72368554 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 3.35090709 |
| 2 | MP0002796_impaired_skin_barrier | 3.32920341 |
| 3 | MP0004264_abnormal_extraembryonic_tissu | 3.28148081 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.22116013 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 3.21239771 |
| 6 | MP0005671_abnormal_response_to | 3.08179076 |
| 7 | MP0006082_CNS_inflammation | 3.06788043 |
| 8 | MP0005083_abnormal_biliary_tract | 2.87486437 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.77162064 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.71759458 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.59172701 |
| 12 | MP0000685_abnormal_immune_system | 2.57378175 |
| 13 | MP0001800_abnormal_humoral_immune | 2.54704785 |
| 14 | MP0001790_abnormal_immune_system | 2.47965036 |
| 15 | MP0005387_immune_system_phenotype | 2.47965036 |
| 16 | MP0009840_abnormal_foam_cell | 2.47584290 |
| 17 | MP0001873_stomach_inflammation | 2.47554645 |
| 18 | MP0005025_abnormal_response_to | 2.46071721 |
| 19 | MP0002723_abnormal_immune_serum | 2.45524354 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.42797399 |
| 21 | MP0001819_abnormal_immune_cell | 2.39013605 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.36277667 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.35751332 |
| 24 | MP0003950_abnormal_plasma_membrane | 2.31357317 |
| 25 | MP0002419_abnormal_innate_immunity | 2.30906055 |
| 26 | MP0003866_abnormal_defecation | 2.30855544 |
| 27 | MP0000465_gastrointestinal_hemorrhage | 2.28119361 |
| 28 | MP0003436_decreased_susceptibility_to | 2.24813522 |
| 29 | MP0002098_abnormal_vibrissa_morphology | 2.22701472 |
| 30 | MP0009785_altered_susceptibility_to | 2.19547822 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 2.17687726 |
| 32 | MP0005501_abnormal_skin_physiology | 2.17228693 |
| 33 | MP0002396_abnormal_hematopoietic_system | 2.15135166 |
| 34 | MP0010155_abnormal_intestine_physiology | 2.15074671 |
| 35 | MP0003724_increased_susceptibility_to | 2.10117663 |
| 36 | MP0002398_abnormal_bone_marrow | 2.09107520 |
| 37 | MP0000716_abnormal_immune_system | 2.02769407 |
| 38 | MP0003303_peritoneal_inflammation | 2.01894876 |
| 39 | MP0002877_abnormal_melanocyte_morpholog | 1.99539985 |
| 40 | MP0002405_respiratory_system_inflammati | 1.99107267 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.99073638 |
| 42 | MP0001216_abnormal_epidermal_layer | 1.97316230 |
| 43 | MP0004947_skin_inflammation | 1.94046890 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.90774371 |
| 45 | MP0005075_abnormal_melanosome_morpholog | 1.82961463 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.82537014 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.82464156 |
| 48 | MP0008875_abnormal_xenobiotic_pharmacok | 1.80019724 |
| 49 | MP0004782_abnormal_surfactant_physiolog | 1.76899531 |
| 50 | MP0004381_abnormal_hair_follicle | 1.76137456 |
| 51 | MP0002722_abnormal_immune_system | 1.74275289 |
| 52 | MP0003690_abnormal_glial_cell | 1.72174716 |
| 53 | MP0005174_abnormal_tail_pigmentation | 1.70614102 |
| 54 | MP0003566_abnormal_cell_adhesion | 1.67487146 |
| 55 | MP0002429_abnormal_blood_cell | 1.67382395 |
| 56 | MP0000604_amyloidosis | 1.66080627 |
| 57 | MP0001851_eye_inflammation | 1.63740166 |
| 58 | MP0005310_abnormal_salivary_gland | 1.63578178 |
| 59 | MP0000678_abnormal_parathyroid_gland | 1.56254464 |
| 60 | MP0000427_abnormal_hair_cycle | 1.54692450 |
| 61 | MP0000490_abnormal_crypts_of | 1.54147733 |
| 62 | MP0002933_joint_inflammation | 1.53160144 |
| 63 | MP0005076_abnormal_cell_differentiation | 1.52140458 |
| 64 | MP0001845_abnormal_inflammatory_respons | 1.52033693 |
| 65 | MP0009780_abnormal_chondrocyte_physiolo | 1.51959901 |
| 66 | MP0001881_abnormal_mammary_gland | 1.51374650 |
| 67 | MP0000703_abnormal_thymus_morphology | 1.50643614 |
| 68 | MP0000627_abnormal_mammary_gland | 1.50009884 |
| 69 | MP0002060_abnormal_skin_morphology | 1.48488533 |
| 70 | MP0002166_altered_tumor_susceptibility | 1.43386080 |
| 71 | MP0003183_abnormal_peptide_metabolism | 1.34046027 |
| 72 | MP0000377_abnormal_hair_follicle | 1.31576852 |
| 73 | MP0000579_abnormal_nail_morphology | 1.28526711 |
| 74 | MP0003329_amyloid_beta_deposits | 1.26052586 |
| 75 | MP0001533_abnormal_skeleton_physiology | 1.25751796 |
| 76 | MP0005451_abnormal_body_composition | 1.24486988 |
| 77 | MP0002254_reproductive_system_inflammat | 1.24338337 |
| 78 | MP0010771_integument_phenotype | 1.21212683 |
| 79 | MP0005165_increased_susceptibility_to | 1.17568107 |
| 80 | MP0002006_tumorigenesis | 1.17503652 |
| 81 | MP0001663_abnormal_digestive_system | 1.16523946 |
| 82 | MP0009278_abnormal_bone_marrow | 1.16217381 |
| 83 | MP0004147_increased_porphyrin_level | 1.15718158 |
| 84 | MP0001666_abnormal_nutrient_absorption | 1.15468700 |
| 85 | MP0005023_abnormal_wound_healing | 1.15046050 |
| 86 | MP0005397_hematopoietic_system_phenotyp | 1.13696506 |
| 87 | MP0001545_abnormal_hematopoietic_system | 1.13696506 |
| 88 | MP0009931_abnormal_skin_appearance | 1.12022234 |
| 89 | MP0003448_altered_tumor_morphology | 1.11860440 |
| 90 | MP0003941_abnormal_skin_development | 1.11576360 |
| 91 | MP0003191_abnormal_cellular_cholesterol | 1.10866500 |
| 92 | MP0008469_abnormal_protein_level | 1.09837786 |
| 93 | MP0000371_diluted_coat_color | 1.06577389 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 1.06541675 |
| 95 | MP0005164_abnormal_response_to | 1.04256052 |
| 96 | MP0001243_abnormal_dermal_layer | 1.04010849 |
| 97 | MP0004510_myositis | 1.03060081 |
| 98 | MP0003453_abnormal_keratinocyte_physiol | 1.02912233 |
| 99 | MP0003705_abnormal_hypodermis_morpholog | 1.01760676 |
| 100 | MP0000467_abnormal_esophagus_morphology | 1.01473482 |
| 101 | MP0010678_abnormal_skin_adnexa | 1.01172794 |
| 102 | MP0000383_abnormal_hair_follicle | 1.00708875 |
| 103 | MP0003045_fibrosis | 0.98432827 |
| 104 | MP0005381_digestive/alimentary_phenotyp | 0.96504494 |
| 105 | MP0003634_abnormal_glial_cell | 0.96161016 |
| 106 | MP0001765_abnormal_ion_homeostasis | 0.95696826 |
| 107 | MP0004233_abnormal_muscle_weight | 0.95579090 |
| 108 | MP0000538_abnormal_urinary_bladder | 0.95032556 |
| 109 | MP0001727_abnormal_embryo_implantation | 0.94714438 |
| 110 | MP0000343_altered_response_to | 0.94547084 |
| 111 | MP0000367_abnormal_coat/_hair | 0.90988488 |
| 112 | MP0001191_abnormal_skin_condition | 0.89590918 |
| 113 | MP0005409_darkened_coat_color | 0.88096571 |
| 114 | MP0003806_abnormal_nucleotide_metabolis | 0.87780444 |
| 115 | MP0004742_abnormal_vestibular_system | 0.86879140 |
| 116 | MP0009764_decreased_sensitivity_to | 0.86830059 |
| 117 | MP0001853_heart_inflammation | 0.85335345 |
| 118 | MP0002168_other_aberrant_phenotype | 0.83956358 |
| 119 | MP0000477_abnormal_intestine_morphology | 0.83955638 |
| 120 | MP0004019_abnormal_vitamin_homeostasis | 0.83827288 |
| 121 | MP0009643_abnormal_urine_homeostasis | 0.82090798 |
| 122 | MP0002998_abnormal_bone_remodeling | 0.82077458 |
| 123 | MP0008057_abnormal_DNA_replication | 0.81179670 |
| 124 | MP0003878_abnormal_ear_physiology | 0.81169117 |
| 125 | MP0005377_hearing/vestibular/ear_phenot | 0.81169117 |
| 126 | MP0003638_abnormal_response/metabolism_ | 0.80363980 |
| 127 | MP0001542_abnormal_bone_strength | 0.80163201 |
| 128 | MP0002896_abnormal_bone_mineralization | 0.79665572 |
| 129 | MP0000015_abnormal_ear_pigmentation | 0.78087819 |
| 130 | MP0004185_abnormal_adipocyte_glucose | 0.77773681 |
| 131 | MP0008873_increased_physiological_sensi | 0.77377472 |
| 132 | MP0005390_skeleton_phenotype | 0.77043807 |
| 133 | MP0002019_abnormal_tumor_incidence | 0.74226890 |
| 134 | MP0009765_abnormal_xenobiotic_induced | 0.73994803 |
| 135 | MP0008260_abnormal_autophagy | 0.73272988 |
| 136 | MP0000858_altered_metastatic_potential | 0.72498517 |
| 137 | MP0001348_abnormal_lacrimal_gland | 0.69922231 |
| 138 | MP0004808_abnormal_hematopoietic_stem | 0.69781468 |
| 139 | MP0002229_neurodegeneration | 0.67591812 |
| 140 | MP0000470_abnormal_stomach_morphology | 0.66569052 |
| 141 | MP0003075_altered_response_to | 0.66409003 |
| 142 | MP0009763_increased_sensitivity_to | 0.65764124 |
| 143 | MP0005166_decreased_susceptibility_to | 0.63107382 |
| 144 | MP0001905_abnormal_dopamine_level | 0.59309047 |
| 145 | MP0003632_abnormal_nervous_system | 0.57961611 |
| 146 | MP0010352_gastrointestinal_tract_polyps | 0.55935093 |
| 147 | MP0001485_abnormal_pinna_reflex | 0.55170228 |
| 148 | MP0001849_ear_inflammation | 0.54452989 |
| 149 | MP0002095_abnormal_skin_pigmentation | 0.54292002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.57239033 |
| 2 | Stomatitis (HP:0010280) | 4.49362894 |
| 3 | T lymphocytopenia (HP:0005403) | 4.48168743 |
| 4 | Chronic otitis media (HP:0000389) | 4.31795174 |
| 5 | Abnormality of T cell number (HP:0011839) | 4.18835471 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.15294837 |
| 7 | Recurrent fungal infections (HP:0002841) | 3.84435141 |
| 8 | Recurrent viral infections (HP:0004429) | 3.78088214 |
| 9 | Eczematoid dermatitis (HP:0000976) | 3.73700841 |
| 10 | Abnormality of macrophages (HP:0004311) | 3.72586638 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 3.64782713 |
| 12 | Neurofibrillary tangles (HP:0002185) | 3.60870049 |
| 13 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.60057223 |
| 14 | Peripheral hypomyelination (HP:0007182) | 3.57015225 |
| 15 | Abnormality of nail color (HP:0100643) | 3.50635135 |
| 16 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.46778478 |
| 17 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.46778478 |
| 18 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.46778478 |
| 19 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.46314443 |
| 20 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.46314443 |
| 21 | Recurrent bacterial skin infections (HP:0005406) | 3.45630950 |
| 22 | Pustule (HP:0200039) | 3.38894325 |
| 23 | Combined immunodeficiency (HP:0005387) | 3.35510009 |
| 24 | J-shaped sella turcica (HP:0002680) | 3.35187456 |
| 25 | Severe combined immunodeficiency (HP:0004430) | 3.34425720 |
| 26 | Increased cerebral lipofuscin (HP:0011813) | 3.32343782 |
| 27 | IgM deficiency (HP:0002850) | 3.31007597 |
| 28 | Abnormality of T cells (HP:0002843) | 3.23420882 |
| 29 | Recurrent skin infections (HP:0001581) | 3.22374715 |
| 30 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.19584362 |
| 31 | Mucopolysacchariduria (HP:0008155) | 3.19584362 |
| 32 | Petechiae (HP:0000967) | 3.15640267 |
| 33 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.11068877 |
| 34 | Slow saccadic eye movements (HP:0000514) | 3.09402629 |
| 35 | Autoimmune thrombocytopenia (HP:0001973) | 3.03578255 |
| 36 | Axonal loss (HP:0003447) | 2.99240757 |
| 37 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.96891527 |
| 38 | Cerebral hypomyelination (HP:0006808) | 2.94544230 |
| 39 | Recurrent bronchitis (HP:0002837) | 2.94134322 |
| 40 | Leukocytosis (HP:0001974) | 2.93122838 |
| 41 | Pili torti (HP:0003777) | 2.92024472 |
| 42 | Hepatosplenomegaly (HP:0001433) | 2.91814494 |
| 43 | Recurrent cutaneous fungal infections (HP:0011370) | 2.91211116 |
| 44 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.91211116 |
| 45 | Myositis (HP:0100614) | 2.85439687 |
| 46 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.84198276 |
| 47 | Abnormality of eosinophils (HP:0001879) | 2.83695910 |
| 48 | Increased IgE level (HP:0003212) | 2.83408528 |
| 49 | Onycholysis (HP:0001806) | 2.83118233 |
| 50 | Chronic diarrhea (HP:0002028) | 2.79722295 |
| 51 | Premature skin wrinkling (HP:0100678) | 2.78261806 |
| 52 | Loss of speech (HP:0002371) | 2.77511976 |
| 53 | Parakeratosis (HP:0001036) | 2.77204686 |
| 54 | Obstructive lung disease (HP:0006536) | 2.76484123 |
| 55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.76484123 |
| 56 | Onion bulb formation (HP:0003383) | 2.75835769 |
| 57 | Thin bony cortex (HP:0002753) | 2.74873665 |
| 58 | Abnormality of glycolipid metabolism (HP:0010969) | 2.72716804 |
| 59 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.72716804 |
| 60 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.72716804 |
| 61 | Short nail (HP:0001799) | 2.70380315 |
| 62 | Thick nail (HP:0001805) | 2.68643217 |
| 63 | Concave nail (HP:0001598) | 2.67624046 |
| 64 | Sensory axonal neuropathy (HP:0003390) | 2.67129195 |
| 65 | Panhypogammaglobulinemia (HP:0003139) | 2.64932583 |
| 66 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.64497518 |
| 67 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.61074275 |
| 68 | Hypokinesia (HP:0002375) | 2.58571380 |
| 69 | Autoimmune hemolytic anemia (HP:0001890) | 2.58412615 |
| 70 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.56112883 |
| 71 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.56112883 |
| 72 | Abnormality of T cell physiology (HP:0011840) | 2.56051481 |
| 73 | Eosinophilia (HP:0001880) | 2.55587640 |
| 74 | Interstitial pulmonary disease (HP:0006530) | 2.55173813 |
| 75 | Amelogenesis imperfecta (HP:0000705) | 2.53349927 |
| 76 | Nasal polyposis (HP:0100582) | 2.53331414 |
| 77 | Supranuclear gaze palsy (HP:0000605) | 2.51009032 |
| 78 | Cerebral inclusion bodies (HP:0100314) | 2.50929223 |
| 79 | Distal lower limb muscle weakness (HP:0009053) | 2.49246586 |
| 80 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.47533466 |
| 81 | Abnormal hair laboratory examination (HP:0003328) | 2.45295972 |
| 82 | Inflammation of the large intestine (HP:0002037) | 2.44782815 |
| 83 | Absent/shortened dynein arms (HP:0200106) | 2.44715924 |
| 84 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.44715924 |
| 85 | Vasculitis (HP:0002633) | 2.44196210 |
| 86 | Gastrointestinal stroma tumor (HP:0100723) | 2.40625181 |
| 87 | Micronodular cirrhosis (HP:0001413) | 2.40274409 |
| 88 | Thyroiditis (HP:0100646) | 2.40228057 |
| 89 | Lymphopenia (HP:0001888) | 2.39163304 |
| 90 | Right ventricular cardiomyopathy (HP:0011663) | 2.37799658 |
| 91 | Purpura (HP:0000979) | 2.36803698 |
| 92 | Dysostosis multiplex (HP:0000943) | 2.35633686 |
| 93 | Abnormality of the corticospinal tract (HP:0002492) | 2.35574365 |
| 94 | Rhinitis (HP:0012384) | 2.35089597 |
| 95 | Chronic bronchitis (HP:0004469) | 2.31953205 |
| 96 | Abnormal ciliary motility (HP:0012262) | 2.31884347 |
| 97 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.30203958 |
| 98 | Granulocytopenia (HP:0001913) | 2.29999597 |
| 99 | Abdominal distention (HP:0003270) | 2.29810632 |
| 100 | Cervical subluxation (HP:0003308) | 2.28538460 |
| 101 | Sparse lateral eyebrow (HP:0005338) | 2.27234149 |
| 102 | Cellulitis (HP:0100658) | 2.26448436 |
| 103 | Gastrointestinal inflammation (HP:0004386) | 2.26075754 |
| 104 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.26028711 |
| 105 | Abnormal auditory evoked potentials (HP:0006958) | 2.25211773 |
| 106 | IgG deficiency (HP:0004315) | 2.25046354 |
| 107 | Alopecia of scalp (HP:0002293) | 2.23105653 |
| 108 | Cardiomegaly (HP:0001640) | 2.22182352 |
| 109 | Hypergammaglobulinemia (HP:0010702) | 2.20913622 |
| 110 | Fragile nails (HP:0001808) | 2.20233268 |
| 111 | Spontaneous hematomas (HP:0007420) | 2.19737185 |
| 112 | Vertebral compression fractures (HP:0002953) | 2.18250451 |
| 113 | Peripheral demyelination (HP:0011096) | 2.15627658 |
| 114 | Nail dystrophy (HP:0008404) | 2.15577435 |
| 115 | Abnormality of B cell number (HP:0010975) | 2.15441308 |
| 116 | B lymphocytopenia (HP:0010976) | 2.15441308 |
| 117 | Plantar hyperkeratosis (HP:0007556) | 2.15220900 |
| 118 | Osteolytic defects of the hand bones (HP:0009699) | 2.13838507 |
| 119 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.13838507 |
| 120 | Clumsiness (HP:0002312) | 2.12037531 |
| 121 | Ileus (HP:0002595) | 2.11875195 |
| 122 | Mediastinal lymphadenopathy (HP:0100721) | 2.11679796 |
| 123 | Progressive neurologic deterioration (HP:0002344) | 2.11304483 |
| 124 | Meningitis (HP:0001287) | 2.11119200 |
| 125 | Gingival bleeding (HP:0000225) | 2.11006210 |
| 126 | Lymphoma (HP:0002665) | 2.08397014 |
| 127 | Cheilitis (HP:0100825) | 2.07805606 |
| 128 | Spastic paraparesis (HP:0002313) | 2.05298381 |
| 129 | Protuberant abdomen (HP:0001538) | 2.04414008 |
| 130 | Abnormal platelet volume (HP:0011876) | 2.04316621 |
| 131 | Prolonged bleeding time (HP:0003010) | 2.02260197 |
| 132 | Bronchiectasis (HP:0002110) | 2.01512480 |
| 133 | Abnormality of the nasal mucosa (HP:0000433) | 2.01127198 |
| 134 | Spastic tetraparesis (HP:0001285) | 1.99902940 |
| 135 | Disinhibition (HP:0000734) | 1.99013387 |
| 136 | Cone-rod dystrophy (HP:0000548) | 1.98765208 |
| 137 | Testicular atrophy (HP:0000029) | 1.97885313 |
| 138 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.97813542 |
| 139 | Rough bone trabeculation (HP:0100670) | 1.96514100 |
| 140 | Bone pain (HP:0002653) | 1.93684702 |
| 141 | Severe short stature (HP:0003510) | 1.93597152 |
| 142 | Milia (HP:0001056) | 1.91916568 |
| 143 | Fatigue (HP:0012378) | 1.91884729 |
| 144 | Epistaxis (HP:0000421) | 1.91751653 |
| 145 | Abnormal trabecular bone morphology (HP:0100671) | 1.90625815 |
| 146 | Lip pit (HP:0100267) | 1.89421678 |
| 147 | Male infertility (HP:0003251) | 1.88976833 |
| 148 | Gingivitis (HP:0000230) | 1.87408024 |
| 149 | Ridged nail (HP:0001807) | 1.86933143 |
| 150 | Diaphragmatic weakness (HP:0009113) | 1.86237007 |
| 151 | Increased serum ferritin (HP:0003281) | 1.85584066 |
| 152 | Vascular calcification (HP:0004934) | 1.85484455 |
| 153 | Restrictive lung disease (HP:0002091) | 1.84536940 |
| 154 | Abnormality of iron homeostasis (HP:0011031) | 1.84262762 |
| 155 | Atrophic scars (HP:0001075) | 1.84066897 |
| 156 | Spastic gait (HP:0002064) | 1.83751236 |
| 157 | Sparse eyelashes (HP:0000653) | 1.81986130 |
| 158 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81890414 |
| 159 | Stridor (HP:0010307) | 1.81554526 |
| 160 | Malnutrition (HP:0004395) | 1.81495486 |
| 161 | Thrombocytosis (HP:0001894) | 1.80883403 |
| 162 | Hydroxyprolinuria (HP:0003080) | 1.80797666 |
| 163 | Abnormality of proline metabolism (HP:0010907) | 1.80797666 |
| 164 | Deformed sella turcica (HP:0002681) | 1.80297573 |
| 165 | Joint stiffness (HP:0001387) | 1.79636806 |
| 166 | Upper limb amyotrophy (HP:0009129) | 1.79437224 |
| 167 | Distal upper limb amyotrophy (HP:0007149) | 1.79437224 |
| 168 | Abnormal blistering of the skin (HP:0008066) | 1.77559382 |
| 169 | Subcapsular cataract (HP:0000523) | 1.77430361 |
| 170 | Tongue fasciculations (HP:0001308) | 1.76415085 |
| 171 | Woolly hair (HP:0002224) | 1.75330268 |
| 172 | Flat acetabular roof (HP:0003180) | 1.75251182 |
| 173 | Type I transferrin isoform profile (HP:0003642) | 1.74440057 |
| 174 | Abnormality of the frontal sinuses (HP:0002687) | 1.73836426 |
| 175 | Aplasia cutis congenita (HP:0001057) | 1.70289308 |
| 176 | Palmoplantar hyperkeratosis (HP:0000972) | 1.69668705 |
| 177 | Hyperparathyroidism (HP:0000843) | 1.67188496 |
| 178 | Septate vagina (HP:0001153) | 1.66680425 |
| 179 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.66644548 |
| 180 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.66534358 |
| 181 | Villous atrophy (HP:0011473) | 1.66534358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 5.38773112 |
| 2 | MST1R | 4.77889852 |
| 3 | MAP4K1 | 4.77566391 |
| 4 | TXK | 3.43292897 |
| 5 | EPHB1 | 3.23824225 |
| 6 | IRAK3 | 3.14542802 |
| 7 | MAPKAPK3 | 3.03892594 |
| 8 | STK39 | 2.81117495 |
| 9 | STK10 | 2.69865049 |
| 10 | TRIB3 | 2.55082841 |
| 11 | TESK2 | 2.52504173 |
| 12 | SIK1 | 2.40546167 |
| 13 | ITK | 2.39624309 |
| 14 | ERN1 | 2.37107528 |
| 15 | PAK4 | 2.33374666 |
| 16 | MST4 | 2.25700027 |
| 17 | KIT | 2.12275392 |
| 18 | BLK | 2.08001644 |
| 19 | RPS6KB2 | 2.05738365 |
| 20 | GRK6 | 2.03086589 |
| 21 | TESK1 | 1.99331599 |
| 22 | MAPKAPK5 | 1.93553711 |
| 23 | ZAP70 | 1.90412641 |
| 24 | OXSR1 | 1.88299039 |
| 25 | IKBKE | 1.87998304 |
| 26 | JAK3 | 1.85922398 |
| 27 | TYK2 | 1.81905883 |
| 28 | SMG1 | 1.81847552 |
| 29 | CLK1 | 1.80398945 |
| 30 | SCYL2 | 1.74990808 |
| 31 | CDK19 | 1.71231960 |
| 32 | PKN2 | 1.69567622 |
| 33 | EIF2AK1 | 1.69349089 |
| 34 | TBK1 | 1.67426044 |
| 35 | LCK | 1.67397401 |
| 36 | MAPK15 | 1.59780006 |
| 37 | IRAK4 | 1.51805411 |
| 38 | CSK | 1.49795935 |
| 39 | BTK | 1.43009501 |
| 40 | PRKCI | 1.38972127 |
| 41 | PTK2 | 1.38711139 |
| 42 | MAP3K14 | 1.36268660 |
| 43 | MAP3K13 | 1.36054154 |
| 44 | PBK | 1.33193026 |
| 45 | NLK | 1.32892354 |
| 46 | PKN1 | 1.31660752 |
| 47 | TRPM7 | 1.28726023 |
| 48 | EEF2K | 1.25894841 |
| 49 | TEC | 1.24251721 |
| 50 | NME2 | 1.22798906 |
| 51 | PRKCQ | 1.21214391 |
| 52 | TLK1 | 1.20923816 |
| 53 | CHUK | 1.20013294 |
| 54 | FGR | 1.19871136 |
| 55 | MAP3K3 | 1.17635555 |
| 56 | CSF1R | 1.17394542 |
| 57 | HCK | 1.16454479 |
| 58 | PIM2 | 1.11437917 |
| 59 | SYK | 1.08994334 |
| 60 | CSNK1G3 | 1.08879019 |
| 61 | LRRK2 | 1.07388391 |
| 62 | IKBKB | 1.07349393 |
| 63 | MAP3K12 | 1.05805669 |
| 64 | ABL2 | 1.03482660 |
| 65 | RPS6KA2 | 1.03125812 |
| 66 | FER | 0.97987078 |
| 67 | CSNK1A1L | 0.94941758 |
| 68 | ICK | 0.94821935 |
| 69 | PTK6 | 0.93248034 |
| 70 | FES | 0.93027394 |
| 71 | CSNK1G1 | 0.90094027 |
| 72 | FGFR4 | 0.89931350 |
| 73 | PIM1 | 0.89193308 |
| 74 | JAK1 | 0.88985998 |
| 75 | CDK12 | 0.86948301 |
| 76 | VRK2 | 0.86493998 |
| 77 | TGFBR2 | 0.82743529 |
| 78 | MAP2K2 | 0.82196310 |
| 79 | MARK2 | 0.81272621 |
| 80 | CDK7 | 0.80202912 |
| 81 | ROCK2 | 0.79700385 |
| 82 | TYRO3 | 0.79337533 |
| 83 | STK16 | 0.78099576 |
| 84 | STK4 | 0.75767365 |
| 85 | MAP3K8 | 0.75627564 |
| 86 | NME1 | 0.74207298 |
| 87 | TNIK | 0.73999893 |
| 88 | PRKCH | 0.73921784 |
| 89 | LYN | 0.73183489 |
| 90 | JAK2 | 0.71556456 |
| 91 | RPS6KA5 | 0.71376864 |
| 92 | MET | 0.71163582 |
| 93 | SIK3 | 0.67136715 |
| 94 | NEK6 | 0.66264426 |
| 95 | FYN | 0.65307323 |
| 96 | MAP2K6 | 0.64723173 |
| 97 | HIPK2 | 0.63707288 |
| 98 | TAOK2 | 0.63472883 |
| 99 | TAOK3 | 0.63437617 |
| 100 | PDK1 | 0.63072626 |
| 101 | MATK | 0.60414585 |
| 102 | RIPK4 | 0.60282945 |
| 103 | CAMK2B | 0.60047187 |
| 104 | LIMK1 | 0.59156132 |
| 105 | RAF1 | 0.58250751 |
| 106 | GRK7 | 0.57596572 |
| 107 | PRKG2 | 0.56581338 |
| 108 | CSNK1G2 | 0.56156731 |
| 109 | LMTK2 | 0.55451315 |
| 110 | ADRBK2 | 0.55243013 |
| 111 | RPS6KC1 | 0.55234942 |
| 112 | RPS6KL1 | 0.55234942 |
| 113 | RPS6KA6 | 0.54284087 |
| 114 | PDGFRB | 0.53890958 |
| 115 | ALK | 0.51385835 |
| 116 | PDPK1 | 0.50259589 |
| 117 | MAP3K11 | 0.49891786 |
| 118 | STK38 | 0.48321779 |
| 119 | MAP2K3 | 0.46857280 |
| 120 | MAP3K7 | 0.46226079 |
| 121 | BMX | 0.46217693 |
| 122 | PRKD1 | 0.43349232 |
| 123 | MAPKAPK2 | 0.42538154 |
| 124 | MAP3K10 | 0.42251971 |
| 125 | PTK2B | 0.41690752 |
| 126 | ABL1 | 0.41439724 |
| 127 | ILK | 0.40973478 |
| 128 | ERBB4 | 0.39503086 |
| 129 | MAP2K1 | 0.39180345 |
| 130 | TAOK1 | 0.38455466 |
| 131 | BRSK2 | 0.38132770 |
| 132 | CAMK2G | 0.38020129 |
| 133 | PRKD2 | 0.37906930 |
| 134 | MAPK4 | 0.37230532 |
| 135 | MARK3 | 0.37190460 |
| 136 | BMPR2 | 0.36566734 |
| 137 | PAK1 | 0.36420036 |
| 138 | WNK1 | 0.35666775 |
| 139 | TNK2 | 0.35342657 |
| 140 | EGFR | 0.34665256 |
| 141 | YES1 | 0.34310158 |
| 142 | UHMK1 | 0.34231907 |
| 143 | KDR | 0.33920172 |
| 144 | MTOR | 0.33822582 |
| 145 | ERBB2 | 0.33620801 |
| 146 | MUSK | 0.33324521 |
| 147 | FGFR2 | 0.33191009 |
| 148 | EIF2AK3 | 0.32765433 |
| 149 | FGFR3 | 0.31674051 |
| 150 | ADRBK1 | 0.31639569 |
| 151 | MAPK7 | 0.30806240 |
| 152 | CDC42BPA | 0.30754820 |
| 153 | BUB1 | 0.30552044 |
| 154 | GSK3A | 0.29414431 |
| 155 | CSNK1D | 0.27650907 |
| 156 | DAPK1 | 0.27394351 |
| 157 | DMPK | 0.27011730 |
| 158 | MELK | 0.26913352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.59558980 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.66406922 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.51691923 |
| 4 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.42319476 |
| 5 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.27752983 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.23528348 |
| 7 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.10391090 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.09720623 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.05950406 |
| 10 | Bladder cancer_Homo sapiens_hsa05219 | 2.03263968 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.02911060 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.00685127 |
| 13 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.90732510 |
| 14 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.89780632 |
| 15 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.89565356 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.89195220 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.87666761 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.86501082 |
| 19 | Lysosome_Homo sapiens_hsa04142 | 1.80794372 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.80552762 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.79337476 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.76515663 |
| 23 | Allograft rejection_Homo sapiens_hsa05330 | 1.75827465 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.73987841 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.72628924 |
| 26 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.71527031 |
| 27 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.70261883 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.62159761 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.59309023 |
| 30 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.57404737 |
| 31 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.56575329 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.47870419 |
| 33 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.46040761 |
| 34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.44275641 |
| 35 | Galactose metabolism_Homo sapiens_hsa00052 | 1.41891895 |
| 36 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.41748691 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.41585967 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.39201642 |
| 39 | Malaria_Homo sapiens_hsa05144 | 1.37108836 |
| 40 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.34260036 |
| 41 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.32185369 |
| 42 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.31389303 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.28468189 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.26518968 |
| 45 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.25853262 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.25718936 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.21913355 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 1.20189779 |
| 49 | Pertussis_Homo sapiens_hsa05133 | 1.17793326 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.16135970 |
| 51 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.15911758 |
| 52 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.15911484 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.10777608 |
| 54 | Mineral absorption_Homo sapiens_hsa04978 | 1.09134117 |
| 55 | Apoptosis_Homo sapiens_hsa04210 | 1.08338810 |
| 56 | Tuberculosis_Homo sapiens_hsa05152 | 1.07590293 |
| 57 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07415084 |
| 58 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.06595473 |
| 59 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06375396 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 1.05702722 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 1.04369991 |
| 62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.03980811 |
| 63 | Histidine metabolism_Homo sapiens_hsa00340 | 1.02174162 |
| 64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.01924536 |
| 65 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.00407778 |
| 66 | Proteasome_Homo sapiens_hsa03050 | 0.99990431 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98486824 |
| 68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.91029766 |
| 69 | Influenza A_Homo sapiens_hsa05164 | 0.90883029 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.90232567 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89387022 |
| 72 | Platelet activation_Homo sapiens_hsa04611 | 0.88825064 |
| 73 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88678803 |
| 74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.88619282 |
| 75 | Hepatitis B_Homo sapiens_hsa05161 | 0.87155550 |
| 76 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.85761663 |
| 77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.85552947 |
| 78 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.84602669 |
| 79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.83615236 |
| 80 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.83132765 |
| 81 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.82542788 |
| 82 | Ribosome_Homo sapiens_hsa03010 | 0.80972975 |
| 83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.80942057 |
| 84 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.80127382 |
| 85 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.79594958 |
| 86 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.78998993 |
| 87 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.77059593 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.76551392 |
| 89 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.75606713 |
| 90 | Legionellosis_Homo sapiens_hsa05134 | 0.73156647 |
| 91 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.71202952 |
| 92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70444337 |
| 93 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.69237796 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67322655 |
| 95 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.65564540 |
| 96 | Viral myocarditis_Homo sapiens_hsa05416 | 0.65416109 |
| 97 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.65214828 |
| 98 | DNA replication_Homo sapiens_hsa03030 | 0.64569172 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64378480 |
| 100 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63878395 |
| 101 | * Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.63677717 |
| 102 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.63178999 |
| 103 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60450678 |
| 104 | Protein export_Homo sapiens_hsa03060 | 0.60327258 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59911913 |
| 106 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59823647 |
| 107 | Phagosome_Homo sapiens_hsa04145 | 0.59096118 |
| 108 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57676644 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56293365 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54183682 |
| 111 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53264159 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.52717944 |
| 113 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52190370 |
| 114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51546052 |
| 115 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.50700372 |
| 116 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48796477 |
| 117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47760423 |
| 118 | Amoebiasis_Homo sapiens_hsa05146 | 0.44965505 |
| 119 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44667289 |
| 120 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44412913 |
| 121 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.43580851 |
| 122 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.42854696 |
| 123 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42042661 |
| 124 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41958961 |
| 125 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41937848 |
| 126 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.41142365 |
| 127 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40497753 |
| 128 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.40447430 |
| 129 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.39953530 |
| 130 | Mismatch repair_Homo sapiens_hsa03430 | 0.39371266 |
| 131 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.38889007 |
| 132 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38714207 |
| 133 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.37647016 |
| 134 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36196998 |
| 135 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35030851 |

